Sarah Cannon Research Institute (Tennessee Oncology) — Nashville, Tennessee

Sarah Cannon Research Institute (Tennessee Oncology) is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute (Tennessee Oncology) has participated in 6 clinical trials with 3 currently active.

Therapeutic areas: Advanced or Metastatic Solid Tumors, Lymphoma, B-Cell, Chronic Lymphocytic Leukemia.

Sponsors: Erasca, Inc., Fate Therapeutics, Katmai Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute (Tennessee Oncology)?

Sarah Cannon Research Institute (Tennessee Oncology) has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute (Tennessee Oncology) conducted?

Sarah Cannon Research Institute (Tennessee Oncology) has 6 clinical trials on record, with 3 currently active. Their work covers Advanced or Metastatic Solid Tumors, Lymphoma, B-Cell, Chronic Lymphocytic Leukemia.

Is Sarah Cannon Research Institute (Tennessee Oncology) accredited by Crixeo Health?

Sarah Cannon Research Institute (Tennessee Oncology) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Research Institute (Tennessee Oncology)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.